XILIO THERAPEUTICS INC
XLO·98422T209·US·Common Stock-13D/G
XLO (XILIO THERAPEUTICS INC) is held by 14 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.1M), RENAISSANCE TECHNOLOGIES LLC ($614,586). Net institutional sentiment: Mixed.
14
Holders
$5.1M
Total Value
59% (17)
Consensus
10 buying - 7 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders Jun 18, 2025 · Activists Aug 14, 2026 · Congress none
ActivistSTStemPoint Capital LP9.5%Aug 14, 2026
ActivistBIBCLS II Equity Opportunities, LP10.0%May 15, 2026
ActivistOAORBIMED ADVISORS LLC10.0%May 15, 2026
Checking access…
Top Holders
Checking access…
Continue exploring
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer